Showing results (191-200 of 244) with videos related to

Sort By:
Pageof 25
Appetite|April 25, 2026
The impact of food advertising on children's daily energy intake: does it differ by advertising content, format, or participant characteristics? A cross-over randomised controlled trialEmma Boyland, Anna E Coates, Mark Green, et al.
Biomaterials|March 18, 2014
Neural differentiation of pluripotent cells in 3D alginate-based culturesAngela Bozza, Emily E Coates, Tania Incitti, et al.
Journal of Pharmacokinetics and Biopharmaceutics|June 1, 1980
Evaluation of the absorption from 15 commercial theophylline products indicating deficiencies in currently applied bioavailability criteriaR A Upton, L Sansom, T W Guentert, et al.
Arthroscopy, Sports Medicine, and Rehabilitation|February 22, 2021
Clinical Outcomes of Superior Capsular Reconstruction for Massive, Irreparable Rotator Cuff Tears: A Systematic Review Comparing Acellular Dermal Allograft and Autograft Fascia LataTyler J Smith, Anirudh K Gowd, John Kunkel, et al.
Archives of Oral Biology|December 15, 2015
The bisphosphonate zoledronic acid regulates key angiogenesis-related genes in primary human gingival fibroblastsE J Ohlrich, D E Coates, M P Cullinan, et al.
Journal of Immunological Methods|February 14, 2021
A sensitive method to quantify HIV-1 antibodies in mucosal samplesMadhu Prabhakaran, Sandeep Narpala, Sarah F Andrews, et al.
Advanced Materials (Deerfield Beach, Fla.)|March 11, 2015
Engineering Synergy: Energy and Mass Transport in Hybrid NanomaterialsEun Seon Cho, Nelson E Coates, Jason D Forster, et al.
The Journal of Trauma|January 12, 2007
Beta-hydroxy-beta-methylbutyrate supplementation in critically ill trauma patientsDeborah A Kuhls, John A Rathmacher, M Diana Musngi, et al.
Implementation Science Communications|January 12, 2021
What's the "secret sauce"? How implementation variation affects the success of colorectal cancer screening outreachJennifer Coury, Edward J Miech, Patricia Styer, et al.
Vaccine|September 10, 2023
Chikungunya virus virus-like particle vaccine is well tolerated and immunogenic in chikungunya seropositive individualsJames M McCarty, Lisa Bedell, Jason Mendy, et al.
Pageof 25